FDA Recall Extended-Release Metformin Due to NDMA Impurities FDA Recall Extended-Release Metformin Due to NDMA Impurities

The FDA advises voluntary recall of extended-release metformin made by five manufacturers after NDMA contamination found in some batches.News Alerts
Source: Medscape FamilyMedicine Headlines - Category: Primary Care Tags: Diabetes & Endocrinology News Alert Source Type: news